Mandate

Vinge advises Karl Hedin and minority owners on the sale of AB Karl Hedin Sågverk to Vida

July 24, 2025

Vinge has advised Karl Hedin and minority shareholders in connection with the sale of AB Karl Hedin Sågverk to Vida Aktiebolag (“Vida”).

Vida is a global supplier of processed products from Swedish forests. The Vida group has approximately 1,600 employees and sales of SEK 12 billion and conducts operations at 24 production facilities, including 12 sawmills. AB Karl Hedin Sågverk has three sawmills in Sweden and a well-established raw materials organisation in Bergslagen. The company has approximately 220 full-time employees and sales of SEK 1.8 billion. Following the acquisition, AB Karl Hedin Sågverk will continue to operate under its current name and trademark with Fredrik Marnefeldt as CEO.

Together Vida and AB Karl Hedin Sågverk will have a turnover of approximately SEK 14 billion, 1,800 employees and a sawmill production of 3.3 million cubic metres.

The transaction is subject to regulatory approvals.

Vinge’s team consisted mainly of Jonas Johansson, Johan Winnerblad, Egil Svensson and Olof Löfvenberg.

Read more in AB Karl Hedin's press release 

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026